At the news
? BULLISHIMPACT 6/10 8-K filed Nov 3, 2026 at 08:16 ET
Revvity reported Q3 2026 adjusted EPS of $1.38, above the $1.30 consensus, on revenue of $729M versus the $694.7M consensus. The company raised its full-year 2026 guidance to pro forma adjusted EPS of $5.40-$5.45 and pro forma revenue of approximately $2.86 billion, citing broad-based growth and strong execution. The filing also included unaudited pro forma financial statements for the planned divestiture of its China Immunodiagnostics business, which is expected to close by the end of 2027.
- Q3 2026 GAAP EPS from continuing operations was $0.56, compared to $0.41 in the prior year period.
- Q3 2026 adjusted EPS from continuing operations was $1.38, compared to $1.18 in the prior year period.
- Q3 2026 revenue was $729 million, compared to $699 million in the prior year period.
- Pro forma revenue for Q3 2026 was $710 million, up 7% year-over-year.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access